Molecular findings in myeloid neoplasms.

Abstract excerpt

The proliferation of new molecular technologies in recent years has greatly advanced our knowledge of the genetics that underlie hematologic cancers. Particularly, with the advent and wide-implementation of next-generation sequencing (NGS), a host of somatic (and some germline) gene mutations have been identified as significant in the classification, prognostication, and treatment of the spectrum of myeloid...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Hematologic Neoplasms
• Share to Leukemia, Myeloid, Acute
• Share to Mutation